Stark COVID-19 Drug Shortages Warning From Senior EU Regulator

EMA Is Liaising With Firms On Potential Treatments And Vaccines

The deputy head of the European Medicines Agency has outlined the steps the agency is taking to assess and address the possibility of drug shortages in Europe caused by the coronavirus outbreak, as the number of cases worldwide tops the 98,000 mark.

Coronavirus could threaten drug supplies in Europe • Source: Shutterstock

The European Medicines Agency has warned about the possibility of a cumulative impact of the COVID-19 outbreak if drug supply problems caused by the coronavirus add to existing product shortages in the EU.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Stark COVID-19 Drug Shortages Warning From Senior EU Regulator

EMA Is Liaising With Firms On Potential Treatments And Vaccines

Read the full article – start your free trial today!

More from Europe

More from Geography